CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels
A smaller bottle gives consumers more flexibility and is cheaper.
SAN DIEGO, Jan. 18, 2023 /PRNewswire/ — CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences” “our”, “us” or “we”), a leading consumer wellness company that specializes in hemp extracts, and other science-backed natural ingredients and products, announced today the launch of their +PlusCBD™ Reserve Collection Softgels In a 30 count bottle. The new offering will be available for purchase on +PlusCBD’sThis website was last updated on Thursday, January 19.
+PlusCBD™ Reserve Collection Softgels Initially launched in August 2022 This is the latest edition of CV Sciences’ Reserve Collection. Available in 60-count containers. Customers who need intense support will feel relief and calm with Reserve Softgels. Reserve Softgels contain a 10-to-1 ratio of CBD to HHC (12.5mg CBD to 1.25mg THC) and are made with a broad range of cannabinoids. They provide consumers with an easy way to get the right amount of cannabinoids. Reserve Softgels now offer a 30-count and a 60-count size option. This allows consumers to personalize their intake at a lower cost. $37.99 USD.
“Consumers have quickly incorporated Reserve Softgels in to their lives, appreciating its simple-to-take format and life-enhancing effects.” Joseph DowlingCV Sciences CEO. Reserve Softgels can now be purchased in smaller quantities (30 count) at a more affordable price. We are confident that this addition will encourage more people, from experts to canna-curious to use cannabis to reduce stress and anxiety.
The +PlusCBD™ Reserve Collection features a variety of product form factors, including gummies and oils in different flavors and potency. Consumers find calm, comfort and relief in the +PlusCBD™ Reserve Collection.
For more information, please visit https://www.pluscbdoil.com/ Email [email protected].
CV Sciences, Inc.
CV Sciences, Inc., (OTCQB, CVSI) a consumer-focused company that specializes in hemp extracts and other science-backed, natural products and ingredients. These products are sold through a range B2B and B2C sales channels. The Company’s +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are one of the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences adheres strictly to Good Manufacturing Practices. All products of the Company are produced and tested in accordance with company specifications. With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. maintains primary offices and facilities in the United States. San Diego, California. OTCMarkets.com offers additional information. www.cvsciences.com.
FORWARD-LOOKING DESCRIPTION
This press release may contain forward-looking information and statements, as defined in Section 27A of Securities Act of 1933, and Section 21E of Securities Exchange Act of 1933. These sections are subject to the Safe Harbor. Forward-looking statements, including statements regarding future events or financial results, are included in this material. These statements can be subject to uncertainties and risks. These forward-looking statements are subject to risks and uncertainties.
Wholesale Contact
[email protected]
Contact Media
MATTIO Communications
Mark Sinclair
[email protected]
Contact Investor Relations
[email protected]
To view original content, you can download multimediahttps://www.prnewswire.com/news-releases/cv-sciences-inc-launches-30-count-of-popular-pluscbd-reserve-collection-softgels-301724226.html
SOURCE CV Sciences, Inc.